NEW YORK (GenomeWeb News) – Response Genetics today announced it has signed a contract that provides the 4.1 million members in Fortified Provider Network access to Response Genetics' molecular predictive tests.

Based in Scottsdale, Ariz., FPN is a direct-contracted network of preferred providers. As a result of today's deal, FPN members associated with more than 200 health insurers, self-funded employers, and other payors of healthcare services will be able to access Response Genetics' tests at discounted rates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.